A 3-Year-Old's Metastatic Cancer Disappeared After Two Doses of Experimental Therapy
15 Articles
15 Articles
Innovative CAR T-cell therapy led to complete remission of metastatic disease in a three-year-old patient who remains disease-free
A 3-Year-Old's Liver Cancer Metastasized to His Lungs. Then, an Experimental Therapy Made It Disappear
Hearing your child has cancer is the worst news a parent can possibly get. For one family, that nightmare became a reality when their 3-year-old son was diagnosed with hepatoblastoma — a condition the National Cancer Institute identifies as the most common type of childhood liver cancer in kids under three. The primary tumor in […]
An experimental cancer treatment has produced remarkable results for a three-year-old boy. After two doses of a modified form of CAR-T cell therapy, there were no more signs of his metastatic liver cancer. Twelve months later, he was still disease-free. CAR-T cell therapy used...
Two doses, one tumor less: sometimes science still knows how to surprise. T-cell therapy with chimeric antigen receptor (CAR-T) is a technique of immunotherapy that consists of removing immune cells from a patient and genetically modifying them to turn them into powerful predators capable of hunting cancer. The treatment has proved very promising in the fight against cancer, although its effectiveness has been limited especially to blood cancers…
A significant advance in cancer medicine has reached a remarkable milestone, as researchers managed to eliminate metastatic cancer in a 3-year-old child with a single dose of an experimental treatment.
Coverage Details
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
